InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: None

Wednesday, 04/05/2017 9:31:19 AM

Wednesday, April 05, 2017 9:31:19 AM

Post# of 21531
http://neurotropebioscience.com/Welcome_to_Neurotrope_BioScience/MAH00009.MP4

Over a quarter Billion $'s spent investigating the actual cause of Alzheimer's. Even their fresh frozen Alzheimer's brains were blinded to prevent bias. Coincidentally Bryostatin even completely cleared the plaque deposits. ( Other companies have huge MC's based on that alone, here it's just a side note or happy coincidence smile. )


4 weeks from video date to top line data results.

Stated there is historically no Placebo response from Severe patients on SIB. I love that they still included a placebo arm in this trial instead of some questionable "historical control" like Anavex. If the "no placebo response on SIB" is correct then the "anecdotal" evidence received thus far is possibly very significant. We will find out soon. Neurotrope won't be pedaling dose optimization results like they actually mean something two years from now. That's how one actually designs a trial to fail quickly.


50 other compounds on tap once hopefully the concept is proven. It even should work in a preventative fashion for Alzheimer's.


Exciting stuff.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News